Figure 2From: Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysisRed blood cell transfusion under argatroban. PRBC transfusion (mean ± SEM) in patients with (A) SAPS <30 and (B) SAPS >30 before and during argatroban therapy during ICU stay. p < 0.05.Back to article page